Sonoma Pharmaceuticals, Inc. Warrants
SNOAW
SNOAW was delisted on the 22nd of January, 2020.
3 hedge funds and large institutions have $5K invested in Sonoma Pharmaceuticals, Inc. Warrants in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
400% more capital invested
Capital invested by funds: $1K → $5K (+$4K)
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$7.88K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.94K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $4K | +$7.88K | +27,867 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $1K | +$1.94K | +6,872 | +5,369% |
|
SNOAW Hedge Fund Activity: Q2 2018 in Review
3 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) for Q2 2018, worth a combined $5K — up 400% from $1K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SNOAW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $7.88K.
- 3 institutional investors held Sonoma Pharmaceuticals, Inc. Warrants (SNOAW) as of Q2 2018, up from 2 in Q1 2018.
- Funds reported $5K of Sonoma Pharmaceuticals, Inc. Warrants stock for Q2 2018, up 400% quarter-over-quarter.
- 1 fund opened new Sonoma Pharmaceuticals, Inc. Warrants positions in Q2 2018 and 0 closed out, a net change of +1 holder.
- The largest Sonoma Pharmaceuticals, Inc. Warrants buyer in Q2 2018 was Susquehanna International Group, an estimated $7.88K added.
Based on aggregated 13F filings for Q2 2018.